Sex- and Age-Stratified Differences in Antidepressant Response to Intranasal Esketamine in Treatment-Resistant Depression: A Secondary Analysis of the REAL-ESK Study
Clinical Neuropsychopharmacology and Addiction · 25.06.2026 · 2 (2)
DOI: 10.53941/cna.2026.100009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Addiction, online erschienen am 25.06.2026. Verfasst von Giacomo d'Andrea und 22 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
Intranasal esketamine (ESK-NS) is an effective treatment for treatment-resistant depression (TRD), but whether antidepressant outcomes differ by sex and age remains insufficiently explored.
Methods
This secondary analysis of the REAL-ESK study included 210 patients with TRD treated with ESK-NS in routine clinical practice and assessed at baseline (T0), one month (T1), and three months (T2). The primary outcome was change in Montgomery–Åsberg Depression Rating Scale (MADRS) scores. Repeated-measures ANOVA tested Time and Time × Sex effects, with post-hoc contrasts corrected using the Holm procedure. Response and remission at T2 were compared by sex. Exploratory analyses stratified patients by age (
Zitieren
APA
d'Andrea, G., Persico, L., Cavallotto, C., Panichella, S., Santeusanio, A., Tullio, A. D., D'Angola, M., Rosati, A., Inserra, A., Tamagnini, G., Puorto, C. D., Salvi, V., Tripodi, B., Berardis, D. D., Martiadis, V., Piccirillo, M., Raffone, F., Vannucchi, T., Barra, A., …, & Pettorruso, M. (2026). Sex- and Age-Stratified Differences in Antidepressant Response to Intranasal Esketamine in Treatment-Resistant Depression: A Secondary Analysis of the REAL-ESK Study. Clinical Neuropsychopharmacology and Addiction, 2(2). https://doi.org/10.53941/cna.2026.100009
Vancouver
d'Andrea G, Persico L, Cavallotto C, Panichella S, Santeusanio A, Tullio AD, et al. Sex- and Age-Stratified Differences in Antidepressant Response to Intranasal Esketamine in Treatment-Resistant Depression: A Secondary Analysis of the REAL-ESK Study. Clinical Neuropsychopharmacology and Addiction. 2026;2(2). doi:10.53941/cna.2026.100009
BibTeX
@article{dAndrea2026,
author = {d'Andrea, Giacomo and Persico, Luca and Cavallotto, Clara and Panichella, Serena and Santeusanio, Alessia and Tullio, Alessandra Di and D'Angola, Michela and Rosati, Arianna and Inserra, Antonio and Tamagnini, Gianfranco and Puorto, Cristina Di and Salvi, Virginio and Tripodi, Beniamino and Berardis, Domenico De and Martiadis, Vassilis and Piccirillo, Milena and Raffone, Fabiola and Vannucchi, Tommaso and Barra, Andrea and Lupi, Matteo and Miotti, Livia and Cesare, Andrea Di and Pettorruso, Mauro},
title = {Sex- and Age-Stratified Differences in Antidepressant Response to Intranasal Esketamine in Treatment-Resistant Depression: A Secondary Analysis of the REAL-ESK Study},
journal = {Clinical Neuropsychopharmacology and Addiction},
year = {2026},
volume = {2},
number = {2},
doi = {10.53941/cna.2026.100009}
}
EUVIMED